Physician profile
Lina Mitchell
NPI 1417906454
$21,903.52
in general payments reported to CMS, 2019-2025
52 companies · $3,315 in 2025
The $3,315 reported for 2025 was more than what 84% of Endocrinology, Diabetes & Metabolism providers received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,708 · 2020: $1,796 · 2021: $2,721 · 2022: $3,037 · 2023: $3,052 · 2024: $3,275 · 2025: $3,315.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,634 · Education: $7.80.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,633.96 |
| Education | $7.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $3,053.81 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Medtronic, INC. | $2,053.43 | 2021-2025 | Minimed 780g, Minimed 770g, Inpen Smart Insulin Delivery System |
| Medtronic Minimed, INC. | $1,464.11 | 2019-2020 | |
| Lilly USA, LLC | $1,348.84 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Astrazeneca Pharmaceuticals Lp | $1,309.04 | 2019-2022 | |
| Amgen INC. | $1,211.80 | 2019-2025 | Evenity, Repatha, Repatha |
| Sanofi-Aventis U.S. LLC | $1,024.59 | 2019-2025 | |
| Beta Bionics, INC. | $932.81 | 2024-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Dexcom, INC. | $858.39 | 2019-2024 | Dexcom G6 Transmitter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $779.63 | 2019-2025 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $750.14 | 2021-2024 | |
| Insulet Corporation | $681.66 | 2019-2025 | Omnipod |
| Tandem Diabetes Care, INC. | $623.23 | 2019-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Corcept Therapeutics | $573.70 | 2019-2024 | Korlym |
| Abbott Laboratories | $570.72 | 2019-2025 | Freestyle Libre 3 |
Show all 52 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lina Mitchell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.